During a three-week maiden voyage to the northern city of Shenyang, the plane's medical volunteers treated 124 patients and provided hands-on surgical training to 18 local doctors.

Novartis-Harvard team identifies a new type of cell that is key to the disease.

Combination of two compounds shows promise in the lab

Manju Ujjini, Head of Lead Discovery for our Global Health Biomedical Research group, discusses what’s next for his team in drug discovery

Researchers from Seattle Children’s and Novartis shed light on developmental brain disorders that lead to intractable epilepsy.

Ask Alan Frohman how he found out that he had glaucoma, and he'll quickly tell you that there were no warning signs.